Evidence map›Paper›PMID 40012401›Full record

ArticleClinical and molecular hepatology2025

Erratum to 'Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial' [Clin Mol Hepatol 2024;30:807-823].

Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S Lee, Ahmed O Kaseb and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and molecular hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Sun Young YimDepartment of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Sung Hwan LeeDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
Seung-Woo BaekMetabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
Bohwa SohnDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yun Seong JeongDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sang-Hee KangDepartment of Surgery, Korea University Guro Hospital, Seoul, Korea.
Kena ParkDepartment of Obstetrics and Gynecology, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
Hyewon ParkDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sunyoung S LeeDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ahmed O KasebDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Young Nyun ParkDepartment of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Sun-Hee LeemDepartment of Biomedical Sciences, Dong-A University, Busan, Korea.
Michael A CurranDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ji Hoon KimDepartment of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Ju-Seog LeeDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40012401
PMCPMC12016622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.